Arkolith/Insider Trading/VRTX/Form 4

Upadhyay Suketu

DirectorVERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed May 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Disposed to issuer(D)796——2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2026Grant(A)3K—$03K
May 1, 2026Grant(A)796——4K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000193) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML